osimertinibNSCLCmetastatic non-small cell lung cancerSABRLCTEGFR-mutated disease
…s of disease, with contemporary randomised data emerging in the osimertinib era and ongoing trials addressing optimal timing and completene…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 505 of 876cotinine-verified
…djusting for relevant covariates.Results Among 8510 adults with cotinine-verified smoking (6754 males; 1756 females), false reporting prevalence …
bevacizumabatezolizumab
… therapy with atezolizumab, an immune checkpoint inhibitor, and bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor. Three d…
4–1BBPD-L1triple-negative breast cancer
…e dual-payload ADC with immune checkpoint inhibitors (PD-L1 and 4–1BB) not only rapidly bridges innate and adaptive immunity but also…
atezolizumabbevacizumabhepatocellular carcinomaGutHCC
…atients, with durable responses to combination regimens such as atezolizumab plus bevacizumab occurring in a minority.1 2 Neutrophils, long …
98.2%
nicotine
…As nicotine pouches have exploded in popularity, a parallel market of ‘ener…
azathioprinehigh-dose corticosteroidsposterior reversible encephalopathy syndromeImmunosuppressive therapyvasculitisreversible cerebral vasoconstriction syndromeintracranial haemorrhages
…d. Immunosuppressive therapy with high-dose corticosteroids and azathioprine was initiated, leading to a gradual improvement of the encephal…
84.6%
PEG-Aspblinatumomabhaematological malignancies
…es induction chemotherapy, including dose-reduced pegaspargase (PEG-Asp), blinatumomab consolidative therapy and HSCT for post-inductio…
lactateimmunotherapysolid tumourschemotherapyradiotherapysurgerycancer
…programming and is instrumental in shaping the TME. Focusing on lactate and lactylation modifications has been shown to markedly improv…
peginterferon alfa-2bexarotenepalmoplantar keratodermaSezary syndrome Stage IVA1exfoliative erythrodermaerythroderma
…s (ECP) two treatments every month, bexarotene 150 mg daily and peginterferon alfa-2 36 ug weekly. Following 7 months of treatment (12 ECP sessions)…
HFNOhead and neck cancersCPP Est 1
…and interfere with surgical conditions. High-flow nasal oxygen (HFNO) has emerged as a promising alternative for maintaining oxygena…